| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.93e-05 | 26 | 158 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.60e-05 | 10 | 158 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | box C/D methylation guide snoRNP complex binding | 6.22e-05 | 2 | 158 | 2 | GO:0062064 | |
| GeneOntologyMolecularFunction | histone modifying activity | 8.96e-05 | 229 | 158 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 1.86e-04 | 3 | 158 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | snoRNP binding | 1.86e-04 | 3 | 158 | 2 | GO:0030519 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 1.86e-04 | 3 | 158 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.00e-04 | 44 | 158 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 5.02e-04 | 20 | 158 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 6.13e-04 | 5 | 158 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.60e-04 | 52 | 158 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 9.14e-04 | 6 | 158 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 9.14e-04 | 6 | 158 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.13e-03 | 147 | 158 | 6 | GO:0042826 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 1.49e-03 | 337 | 158 | 9 | GO:0031625 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.69e-03 | 8 | 158 | 2 | GO:0140945 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.70e-06 | 36 | 158 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.92e-06 | 62 | 158 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.56e-05 | 87 | 158 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYC MIER2 MRE11 SETD1A SETD1B KAT6A RSF1 NASP KDM6B BCOR HP1BP3 SETD2 PRDM9 HLTF KDM4A HDGFL2 NIPBL | 5.61e-05 | 741 | 158 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.08e-05 | 93 | 158 | 6 | GO:0086003 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.58e-06 | 17 | 156 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | super elongation complex | 8.02e-06 | 6 | 156 | 3 | GO:0032783 | |
| GeneOntologyCellularComponent | sodium channel complex | 6.13e-05 | 29 | 156 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | fibrillar center | 1.73e-04 | 156 | 156 | 7 | GO:0001650 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MYC NOLC1 MRE11 SETD1A SP100 GCFC2 SETD1B AFF2 LEO1 PHF12 RSF1 E2F7 KDM6B BCOR PRDM4 ADAR ORC1 DNAJC17 HLTF FIP1L1 AFF1 NIPBL AFF4 | 2.31e-04 | 1377 | 156 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 5.45e-04 | 5 | 156 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | Mre11 complex | 5.45e-04 | 5 | 156 | 2 | GO:0030870 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | MYC NRBP1 MRE11 CDKN3 MAP1B BAG1 MYRIP SPIRE1 PLEKHG5 MAP3K4 FXR1 INF2 SBF2 SCN5A PATJ MYO16 HSP90AA1 | 6.25e-04 | 934 | 156 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 8.11e-04 | 56 | 156 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | box C/D RNP complex | 1.13e-03 | 7 | 156 | 2 | GO:0170049 | |
| GeneOntologyCellularComponent | box C/D methylation guide snoRNP complex | 1.13e-03 | 7 | 156 | 2 | GO:0031428 | |
| GeneOntologyCellularComponent | chromatin | MYC MRE11 SETD1A SPIB PHF12 KAT6A RSF1 E2F7 NASP IRF2 POU3F4 PIAS1 HP1BP3 CCND2 TRIM66 HOXB5 PRDM9 CSRNP3 MKX KDM4A NIPBL AFF4 | 1.50e-03 | 1480 | 156 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear speck | SETD1A SETD1B AFF2 KAT6A E2F7 ADAR PIAS1 SFMBT2 HP1BP3 ZNF106 | 1.52e-03 | 431 | 156 | 10 | GO:0016607 |
| Domain | Na_channel_asu | 9.22e-07 | 10 | 155 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 9.22e-07 | 10 | 155 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 9.22e-07 | 10 | 155 | 4 | PF06512 | |
| Domain | IQ | 1.05e-06 | 93 | 155 | 8 | PS50096 | |
| Domain | TF_AF4/FMR2 | 2.23e-06 | 4 | 155 | 3 | IPR007797 | |
| Domain | AF-4 | 2.23e-06 | 4 | 155 | 3 | PF05110 | |
| Domain | Znf_FYVE_PHD | 3.84e-06 | 147 | 155 | 9 | IPR011011 | |
| Domain | IQ_motif_EF-hand-BS | 9.94e-06 | 90 | 155 | 7 | IPR000048 | |
| Domain | Na_trans_cytopl | 1.10e-05 | 6 | 155 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.10e-05 | 6 | 155 | 3 | IPR024583 | |
| Domain | - | ZFYVE16 PHF12 KAT6A RSF1 MYRIP SPIRE1 RFFL TRIM66 UBE4A RNF146 HLTF SCAF11 KDM4A MGRN1 | 2.33e-05 | 449 | 155 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | ZFYVE16 PHF12 KAT6A RSF1 MYRIP SPIRE1 RFFL TRIM66 UBE4A RNF146 HLTF SCAF11 KDM4A MGRN1 | 2.97e-05 | 459 | 155 | 14 | IPR013083 |
| Domain | SET | 3.84e-05 | 46 | 155 | 5 | SM00317 | |
| Domain | IQ | 5.76e-05 | 81 | 155 | 6 | SM00015 | |
| Domain | SET_dom | 5.79e-05 | 50 | 155 | 5 | IPR001214 | |
| Domain | SET | 5.79e-05 | 50 | 155 | 5 | PS50280 | |
| Domain | N-SET | 6.84e-05 | 2 | 155 | 2 | PF11764 | |
| Domain | N-SET | 6.84e-05 | 2 | 155 | 2 | SM01291 | |
| Domain | COMPASS_Set1_N-SET | 6.84e-05 | 2 | 155 | 2 | IPR024657 | |
| Domain | Channel_four-helix_dom | 1.09e-04 | 57 | 155 | 5 | IPR027359 | |
| Domain | - | 1.09e-04 | 57 | 155 | 5 | 1.20.120.350 | |
| Domain | PDEase_N | 2.04e-04 | 3 | 155 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 2.04e-04 | 3 | 155 | 2 | PF08499 | |
| Domain | Post-SET_dom | 2.90e-04 | 16 | 155 | 3 | IPR003616 | |
| Domain | PostSET | 2.90e-04 | 16 | 155 | 3 | SM00508 | |
| Domain | POST_SET | 2.90e-04 | 16 | 155 | 3 | PS50868 | |
| Domain | SET | 3.64e-04 | 41 | 155 | 4 | PF00856 | |
| Domain | PHD | 8.74e-04 | 89 | 155 | 5 | SM00249 | |
| Domain | Znf_PHD | 9.67e-04 | 91 | 155 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.17e-03 | 95 | 155 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.23e-03 | 96 | 155 | 5 | PS01359 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.00e-05 | 31 | 102 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.95e-05 | 32 | 102 | 4 | M27455 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.05e-04 | 65 | 102 | 5 | M39682 | |
| Pubmed | NOLC1 SETD1A SZT2 PHF12 NACA SPIRE1 KDM6B BCOR PLEKHG5 AFAP1 CELSR3 OSBPL5 SCAF11 KDM4A FAM149B1 PPIP5K2 CFAP97 ZNF687 MGRN1 | 5.28e-12 | 529 | 159 | 19 | 14621295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A SETD1B SZT2 PHF12 UBR4 KAT6A SPIRE1 KDM6B PLEKHG5 C2CD2L HIVEP3 ORC1 CYREN SLC8B1 CELSR3 INF2 PLEKHO2 SBF2 SCN5A SCN8A OSBPL5 TANC1 ZNF579 ZNF687 SPATA13 TJP3 | 7.39e-12 | 1105 | 159 | 26 | 35748872 |
| Pubmed | MYC NOLC1 MRE11 SP100 TCOF1 PHF12 KAT6A RSF1 ZNF629 TMOD3 BCOR EPB41L3 GJD4 C2CD2L TRIM66 SETD2 ZNF469 FXR1 SCN5A FIP1L1 MACF1 TANC1 CRYBG3 ZNF579 AFF4 ZNF687 | 9.20e-12 | 1116 | 159 | 26 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 MRE11 MAP1B ZFYVE16 TCOF1 KTN1 NACA RSF1 TMOD3 NASP BCOR EPB41L3 ADAR HP1BP3 SETD2 FAM169A MACF1 NOPCHAP1 HDGFL2 NIPBL AFF4 HSP90AA1 NOL8 | 5.56e-11 | 934 | 159 | 23 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 NES MAP1B GIT1 BAD ZNF629 SPIRE1 ALPK1 EPB41L3 ZNF106 FXR1 FIP1L1 MACF1 TANC1 CRYBG3 PPIP5K2 PATJ PIBF1 CFAP97 SPATA13 | 2.99e-09 | 861 | 159 | 20 | 36931259 |
| Pubmed | MRE11 PHF12 KTN1 NACA SPIRE1 APLP2 BCOR AP3B1 PIAS1 C2CD2L ORC1 SETD2 AFAP1 RRP9 NOM1 HLTF MACF1 SCAF11 TANC1 ZNF579 PATJ HDGFL2 NIPBL AFF4 ZNF687 NOL8 | 4.84e-09 | 1497 | 159 | 26 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYC NOLC1 MRE11 LEO1 TCOF1 PHF12 KTN1 ZNF629 BCOR ADAR HP1BP3 ORC1 ZNF106 SETD2 RRP9 NOM1 HLTF FIP1L1 SCAF11 QSER1 HDGFL2 NIPBL ZNF687 NOL8 | 5.80e-09 | 1294 | 159 | 24 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 MRE11 SALL3 MAP1B KTN1 RSF1 KRI1 BCOR EPB41L3 ADAR HP1BP3 SETD2 FIP1L1 SCAF11 QSER1 HDGFL2 NIPBL AFF4 HSP90AA1 NOL8 | 1.66e-08 | 954 | 159 | 20 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 MRE11 GCFC2 LEO1 GIT1 TCOF1 PHF12 NASP RFFL BCOR ZNF106 SETD2 FIP1L1 AFF1 SCAF11 ZNF579 NIPBL ZNF687 | 1.92e-08 | 774 | 159 | 18 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIER2 PHF12 KAT6A RSF1 NASP BCOR PIAS1 HP1BP3 FAM169A HLTF SCAF11 KDM4A QSER1 HDGFL2 NIPBL AFF4 | 2.28e-08 | 608 | 159 | 16 | 36089195 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.96e-08 | 148 | 159 | 9 | 32538781 | |
| Pubmed | NES GCFC2 ZFYVE16 KTN1 NACA TMOD3 C2CD2L ZNF106 SETD2 FXR1 ATAD1 FIP1L1 TANC1 QSER1 PPIP5K2 PATJ ZNF687 | 5.06e-08 | 733 | 159 | 17 | 34672954 | |
| Pubmed | 5.21e-08 | 9 | 159 | 4 | 16382098 | ||
| Pubmed | LEO1 MAP1B NACA ZNF629 AP3B1 PIAS1 HP1BP3 CEP78 NOM1 HLTF TANC1 QSER1 CRYBG3 PPIP5K2 PATJ MGRN1 | 5.71e-08 | 650 | 159 | 16 | 38777146 | |
| Pubmed | NOLC1 MRE11 NES MAP1B TCOF1 UBR4 RSF1 KRI1 EPB41L3 HP1BP3 FXR1 RRP9 MACF1 SCAF11 MRTO4 NIPBL | 6.08e-08 | 653 | 159 | 16 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC NOLC1 MRE11 SETD1A NES SETD1B MAP1B KTN1 UBR4 NACA RSF1 EPB41L3 ADAR ORC1 FXR1 INF2 HLTF FIP1L1 MACF1 MRTO4 TANC1 NIPBL HSP90AA1 | 6.10e-08 | 1353 | 159 | 23 | 29467282 |
| Pubmed | 6.32e-08 | 215 | 159 | 10 | 35973513 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 6.81e-08 | 163 | 159 | 9 | 22113938 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 MAP1B KTN1 KAT6A NACA ZNF629 KRI1 ADAR HP1BP3 FXR1 CEP78 RRP9 NOM1 MACF1 SCAF11 MRTO4 NOL8 | 8.33e-08 | 759 | 159 | 17 | 35915203 |
| Pubmed | 8.65e-08 | 10 | 159 | 4 | 28620180 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MYC SETD1A AFF2 TCOF1 UBR4 TSC22D2 PRDM4 PIAS1 ZNF469 SCN10A AFF1 PATJ MGRN1 | 1.04e-07 | 430 | 159 | 13 | 35044719 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | NOLC1 MAP1B GIT1 TCOF1 EPB41L3 HP1BP3 CCND2 AFF1 PATJ HDGFL2 AFF4 ZNF687 HSP90AA1 | 1.09e-07 | 432 | 159 | 13 | 23455922 |
| Pubmed | MRE11 GIT1 KTN1 UBR4 ADAR HP1BP3 FXR1 CEP78 NOM1 SBF2 MACF1 C3 SCAF11 MRTO4 HDGFL2 | 1.27e-07 | 601 | 159 | 15 | 33658012 | |
| Pubmed | NOLC1 MRE11 SALL3 PHTF2 NASP SPIRE1 BCOR AP3B1 CCND2 AREL1 FXR1 INF2 SBF2 MKX AFF1 MACF1 ANKRD12 QSER1 PATJ AFF4 | 1.32e-07 | 1084 | 159 | 20 | 11544199 | |
| Pubmed | NRBP1 MRE11 SETD1B SZT2 PHF12 UBR4 ZNF629 E2F7 NASP IRF2 APLP2 TSC22D2 PRDM4 PIAS1 UBE4A ZNF106 SETD2 FXR1 ATAD1 FAM169A KDM4A NIPBL | 1.87e-07 | 1327 | 159 | 22 | 32694731 | |
| Pubmed | MYC NOLC1 MRE11 LEO1 UBR4 RSF1 ADAR PIAS1 HP1BP3 SETD2 DNAJC17 HLTF FIP1L1 QSER1 HDGFL2 NIPBL MAGEC2 ZNF687 HSP90AA1 | 2.20e-07 | 1014 | 159 | 19 | 32416067 | |
| Pubmed | 2.49e-07 | 57 | 159 | 6 | 18022353 | ||
| Pubmed | 2.91e-07 | 13 | 159 | 4 | 15123669 | ||
| Pubmed | MRE11 NES SP100 ZFYVE16 NACA ADAR DNAJC17 AFAP1 MACF1 TANC1 CRYBG3 HDGFL2 ZNF687 | 3.01e-07 | 472 | 159 | 13 | 38943005 | |
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 3.74e-07 | 4 | 159 | 3 | 11923441 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 3.74e-07 | 4 | 159 | 3 | 15459319 | |
| Pubmed | MRE11 TCOF1 KTN1 ZNF629 TMOD3 KRI1 ADAR HP1BP3 FXR1 RRP9 NOM1 FIP1L1 SCAF11 MRTO4 ZNF687 HSP90AA1 NOL8 | 3.89e-07 | 847 | 159 | 17 | 35850772 | |
| Pubmed | NRBP1 GPRASP1 LEO1 GIT1 TCOF1 UBR4 MYRIP NASP NBEA KDM6B PRDM4 PIAS1 TRIM66 UBE4A CELSR3 FIP1L1 MACF1 KDM4A NIPBL AFF4 HSP90AA1 | 4.60e-07 | 1285 | 159 | 21 | 35914814 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MRE11 SETD1A MAP1B TCOF1 KRI1 ZNF106 OSBPL5 FIP1L1 SCAF11 MRTO4 QSER1 NIPBL | 4.61e-07 | 410 | 159 | 12 | 26949251 |
| Pubmed | MIER2 KTN1 ZNF629 ALPK1 ARMCX2 EPB41L3 HIVEP3 TRIM66 UBE4A SETD2 SBF2 FAM169A MACF1 | 4.91e-07 | 493 | 159 | 13 | 15368895 | |
| Pubmed | NOLC1 SP100 LEO1 MAP1B KTN1 UBR4 RSF1 BAG1 MYRIP EPB41L3 SFMBT2 HP1BP3 FXR1 SCN9A FAM169A MACF1 PPIP5K2 DTHD1 HDGFL2 NIPBL HSP90AA1 SPATA13 | 7.56e-07 | 1442 | 159 | 22 | 35575683 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 MRE11 LEO1 TCOF1 KRI1 ADAR HP1BP3 NOM1 FIP1L1 SCAF11 MRTO4 HDGFL2 ZNF687 HSP90AA1 | 8.34e-07 | 605 | 159 | 14 | 28977666 |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 9.31e-07 | 5 | 159 | 3 | 22875929 | |
| Pubmed | 1.08e-06 | 40 | 159 | 5 | 28805822 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SGSM1 MAP1B KAT6A BAD MYRIP SPIRE1 SFMBT2 HP1BP3 HIVEP3 SLC8B1 INF2 SBF2 OSBPL5 AFF1 MACF1 SCAF11 TANC1 ANKRD12 QSER1 PATJ AFF4 MGRN1 | 1.28e-06 | 1489 | 159 | 22 | 28611215 |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 16029194 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.86e-06 | 6 | 159 | 3 | 23652591 | |
| Pubmed | NOLC1 MRE11 NES NACA TMOD3 ADAR HP1BP3 FXR1 AFAP1 INF2 RRP9 MACF1 MRTO4 HDGFL2 | 2.30e-06 | 660 | 159 | 14 | 32780723 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 NES MAP1B TCOF1 ZNF629 APLP2 EPB41L3 ADAR HP1BP3 SETD2 AFAP1 MKX FIP1L1 MACF1 PPIP5K2 NIPBL AFF4 HSP90AA1 | 2.53e-06 | 1082 | 159 | 18 | 38697112 |
| Pubmed | 2.55e-06 | 251 | 159 | 9 | 31076518 | ||
| Pubmed | MYC SP100 KTN1 BAD APLP2 EPB41L3 PIAS1 MAP3K4 ZNF106 MACF1 PIBF1 HSP90AA1 | 2.70e-06 | 486 | 159 | 12 | 20936779 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYC NOLC1 NES TCOF1 NASP KRI1 ADAR ORC1 ZNF106 RRP9 HLTF FIP1L1 SCAF11 MRTO4 AFF4 HSP90AA1 NOL8 | 3.18e-06 | 989 | 159 | 17 | 36424410 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KTN1 NASP NBEA EPB41L3 MAP3K4 HP1BP3 ZNF106 SCN9A KDM4A HDGFL2 NACA4P ZNF687 | 3.40e-06 | 497 | 159 | 12 | 36774506 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETD1B LEO1 GIT1 TCOF1 ZNF629 E2F7 BCOR PIAS1 SETD2 MACF1 TANC1 CRYBG3 PATJ | 3.43e-06 | 588 | 159 | 13 | 38580884 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NES MAP1B KTN1 UBR4 NBEA EPB41L3 AP3B1 HP1BP3 FXR1 ATAD1 MACF1 PPIP5K2 | 3.47e-06 | 498 | 159 | 12 | 36634849 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.76e-06 | 139 | 159 | 7 | 16985003 | |
| Pubmed | NOLC1 NRBP1 LEO1 TCOF1 RSF1 NASP EPB41L3 ADAR FIP1L1 ZNF579 NIPBL ZNF687 | 3.84e-06 | 503 | 159 | 12 | 16964243 | |
| Pubmed | NOLC1 NRBP1 TCOF1 KTN1 UBR4 BAG1 KRI1 EPB41L3 AP3B1 HP1BP3 UBE4A DNAJC17 INF2 RRP9 MACF1 MRTO4 TANC1 CRYBG3 PIBF1 HDGFL2 NOL8 | 4.60e-06 | 1487 | 159 | 21 | 33957083 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A SETD1B GIT1 TCOF1 ADAR MAP3K4 SETD2 FXR1 RRP9 FIP1L1 ZNF687 | 6.34e-06 | 440 | 159 | 11 | 34244565 |
| Pubmed | 6.57e-06 | 282 | 159 | 9 | 23667531 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MRE11 MAP1B GIT1 KTN1 ZNF629 EPB41L3 AP3B1 ADAR FXR1 CEP78 NOM1 FIP1L1 MACF1 NOL8 | 6.63e-06 | 724 | 159 | 14 | 36232890 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 7.48e-06 | 364 | 159 | 10 | 24778252 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 MRE11 LEO1 GIT1 TCOF1 KTN1 UBR4 NACA KRI1 AP3B1 HP1BP3 FXR1 DNAJC17 HLTF MACF1 SCAF11 MRTO4 HDGFL2 NIPBL HSP90AA1 | 7.82e-06 | 1415 | 159 | 20 | 28515276 |
| Pubmed | 8.71e-06 | 104 | 159 | 6 | 9205841 | ||
| Pubmed | 9.01e-06 | 222 | 159 | 8 | 37071664 | ||
| Pubmed | 9.07e-06 | 61 | 159 | 5 | 20305087 | ||
| Pubmed | NES PDE1C MAP1B GIT1 DOCK8 KTN1 TMOD3 SPIRE1 NBEA EPB41L3 AP3B1 PLEKHG5 HP1BP3 PNMA8B FXR1 AFAP1 INF2 MACF1 TANC1 HSP90AA1 | 9.22e-06 | 1431 | 159 | 20 | 37142655 | |
| Pubmed | MAP1B GIT1 ZFYVE16 RSF1 ZNF629 NASP EPB41L3 DNAJC17 FAM169A FIP1L1 C3 PIBF1 ZNF687 | 9.26e-06 | 645 | 159 | 13 | 25281560 | |
| Pubmed | MRE11 SETD1A MAP1B TCOF1 KTN1 NASP BCOR AP3B1 ADAR SETD2 QSER1 PATJ | 9.26e-06 | 549 | 159 | 12 | 38280479 | |
| Pubmed | GPRASP1 NES GIT1 TCOF1 KTN1 UBR4 NBEA BCOR EPB41L3 FXR1 MACF1 QSER1 NIPBL AFF4 HSP90AA1 SPATA13 | 9.61e-06 | 963 | 159 | 16 | 28671696 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 MRE11 SETD1A TCOF1 UBR4 NACA NASP KRI1 AP3B1 ADAR HP1BP3 FXR1 RRP9 HLTF MRTO4 PPIP5K2 NIPBL ZNF687 HSP90AA1 | 1.02e-05 | 1318 | 159 | 19 | 30463901 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.24e-05 | 232 | 159 | 8 | 25515538 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.67e-05 | 317 | 159 | 9 | 17620599 | |
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 1.79e-05 | 118 | 159 | 6 | 19690564 | |
| Pubmed | 1.89e-05 | 246 | 159 | 8 | 15345747 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 MRE11 SP100 NACA TMOD3 KRI1 ADAR HP1BP3 FXR1 AFAP1 RRP9 NOM1 C3 SCAF11 MRTO4 PATJ HSP90AA1 NOL8 | 1.94e-05 | 1257 | 159 | 18 | 36526897 |
| Pubmed | A high-density association screen of 155 ion transport genes for involvement with common migraine. | 2.00e-05 | 12 | 159 | 3 | 18676988 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 2.08e-05 | 2 | 159 | 2 | 24642470 | |
| Pubmed | FXR1 is a novel MRE11-binding partner and participates in oxidative stress responses. | 2.08e-05 | 2 | 159 | 2 | 32211858 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 14988024 | ||
| Pubmed | Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. | 2.08e-05 | 2 | 159 | 2 | 14724288 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 37528066 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15047701 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 28262675 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22474336 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24843025 | ||
| Pubmed | Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | 2.08e-05 | 2 | 159 | 2 | 37166351 | |
| Pubmed | Up-regulation of Kir2.1 (KCNJ2) by the serum & glucocorticoid inducible SGK3. | 2.08e-05 | 2 | 159 | 2 | 24556932 | |
| Pubmed | Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression. | 2.08e-05 | 2 | 159 | 2 | 34862309 | |
| Pubmed | Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC. | 2.08e-05 | 2 | 159 | 2 | 21986497 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 2.08e-05 | 2 | 159 | 2 | 27174182 | |
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 2.08e-05 | 2 | 159 | 2 | 24998131 | |
| Pubmed | Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis. | 2.08e-05 | 2 | 159 | 2 | 11369604 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11355014 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24360055 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 32330377 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26861708 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 2.08e-05 | 2 | 159 | 2 | 16111501 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26305500 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24813121 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31292628 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24550110 | ||
| Pubmed | In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | 2.08e-05 | 2 | 159 | 2 | 38003223 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27239040 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26007649 | ||
| Interaction | CSNK2A1 interactions | MYC NOLC1 SETD1A GCFC2 LEO1 SPIB TCOF1 KAT6A NACA RSF1 TMOD3 IRF2 XK BCOR EPB41L3 PIAS1 HP1BP3 FXR1 INF2 RRP9 FIP1L1 MACF1 HDGFL2 CFAP97 ZNF687 HSP90AA1 | 2.44e-08 | 956 | 157 | 26 | int:CSNK2A1 |
| Interaction | CSNK2B interactions | MYC NOLC1 NRBP1 LEO1 TCOF1 KAT6A KDM6B BCOR EPB41L3 ORC1 ZNF106 HOXB5 SETD2 FXR1 AFAP1 HDGFL2 CFAP97 ZNF687 HSP90AA1 TJP3 | 9.13e-08 | 625 | 157 | 20 | int:CSNK2B |
| Interaction | H2BC21 interactions | MYC MRE11 LEO1 MAP1B PHF12 KAT6A RSF1 KDM6B BCOR EPB41L3 SFMBT2 HP1BP3 C2CD2L ORC1 ATAD1 CEP78 HLTF SCAF11 QSER1 NIPBL ZNF687 | 1.14e-07 | 696 | 157 | 21 | int:H2BC21 |
| Interaction | KIF21A interactions | 1.33e-07 | 105 | 157 | 9 | int:KIF21A | |
| Interaction | TERF2IP interactions | MYC MRE11 SETD1A SP100 LEO1 RSF1 NASP BCOR PIAS1 HP1BP3 ORC1 SETD2 SCAF11 MRTO4 QSER1 NIPBL AFF4 ZNF687 | 3.21e-07 | 552 | 157 | 18 | int:TERF2IP |
| Interaction | PLCD3 interactions | 4.51e-07 | 121 | 157 | 9 | int:PLCD3 | |
| Interaction | PIP4K2A interactions | MYC NOLC1 SP100 SETD1B TCOF1 EPB41L3 AP3B1 SETD2 AFF1 HDGFL2 AFF4 | 1.06e-06 | 216 | 157 | 11 | int:PIP4K2A |
| Interaction | RASA2 interactions | 1.55e-06 | 26 | 157 | 5 | int:RASA2 | |
| Interaction | NAA40 interactions | NOLC1 MRE11 MAP1B ZFYVE16 TCOF1 KTN1 NACA RSF1 TMOD3 NASP BCOR EPB41L3 ADAR HP1BP3 SETD2 FAM169A MACF1 NOPCHAP1 HDGFL2 NIPBL AFF4 HSP90AA1 NOL8 | 2.13e-06 | 978 | 157 | 23 | int:NAA40 |
| Interaction | TOP3B interactions | SETD1A SETD1B SZT2 PHF12 KTN1 UBR4 KAT6A SPIRE1 KDM6B PLEKHG5 C2CD2L HIVEP3 ORC1 CYREN FXR1 SLC8B1 CELSR3 INF2 PLEKHO2 SBF2 SCN5A SCN8A OSBPL5 KDM4A TANC1 ZNF579 ZNF687 SPATA13 TJP3 | 3.01e-06 | 1470 | 157 | 29 | int:TOP3B |
| Interaction | SCN11A interactions | 4.53e-06 | 15 | 157 | 4 | int:SCN11A | |
| Interaction | H1-2 interactions | MYC MRE11 SP100 SETD1B LEO1 TCOF1 KAT6A RSF1 NASP KRI1 APLP2 KDM6B HP1BP3 FXR1 RNF146 FIP1L1 MRTO4 TANC1 | 4.62e-06 | 666 | 157 | 18 | int:H1-2 |
| Interaction | DDX23 interactions | MYC NOLC1 GCFC2 LEO1 MAP1B TCOF1 ZNF629 KRI1 SETD2 DNAJC17 FIP1L1 SCAF11 HDGFL2 AFF4 NOL8 | 5.46e-06 | 480 | 157 | 15 | int:DDX23 |
| Interaction | CIT interactions | NOLC1 GPRASP1 NES TCOF1 KTN1 UBR4 NACA RSF1 KRI1 SPIRE1 ADAR MAP3K4 HP1BP3 FXR1 ATAD1 INF2 RRP9 HLTF FIP1L1 MACF1 SCAF11 PATJ PIBF1 HDGFL2 NIPBL NACA4P ZNF687 HSP90AA1 | 6.87e-06 | 1450 | 157 | 28 | int:CIT |
| Interaction | CBX3 interactions | MYC SETD1A SP100 TCOF1 RSF1 ZNF629 KDM6B BCOR PIAS1 HP1BP3 CCND2 TRIM66 SETD2 MACF1 HDGFL2 NIPBL NOL8 | 1.22e-05 | 646 | 157 | 17 | int:CBX3 |
| Interaction | YWHAG interactions | MYC NOLC1 NRBP1 GIT1 BAD BAG1 ZNF629 SPIRE1 EPB41L3 PLEKHG5 PIAS1 C2CD2L ZNF106 FXR1 CEP78 FIP1L1 MACF1 SCAF11 TANC1 PPIP5K2 PATJ PIBF1 CFAP97 HSP90AA1 SPATA13 | 1.24e-05 | 1248 | 157 | 25 | int:YWHAG |
| Interaction | MEN1 interactions | MYC NOLC1 MRE11 SETD1A SETD1B TCOF1 KTN1 UBR4 ZNF629 KRI1 ADAR HP1BP3 FXR1 NOM1 FIP1L1 SCAF11 MRTO4 QSER1 AFF4 ZNF687 HSP90AA1 NOL8 | 1.63e-05 | 1029 | 157 | 22 | int:MEN1 |
| Interaction | BOD1L1 interactions | 2.23e-05 | 149 | 157 | 8 | int:BOD1L1 | |
| Interaction | PRC1 interactions | MYC NOLC1 MRE11 NES MAGEA9 KTN1 NACA RSF1 TMOD3 ADAR MAP3K4 HP1BP3 FXR1 AFAP1 CELSR3 ATAD1 INF2 RRP9 HLTF FIP1L1 PATJ | 2.25e-05 | 973 | 157 | 21 | int:PRC1 |
| Interaction | H3-3A interactions | MYC SETD1A SETD1B KAT6A RSF1 NASP KDM6B BCOR PIAS1 HP1BP3 OSBPL5 HLTF SCAF11 KDM4A QSER1 HDGFL2 NIPBL AFF4 | 2.26e-05 | 749 | 157 | 18 | int:H3-3A |
| Interaction | ZNF281 interactions | 2.47e-05 | 197 | 157 | 9 | int:ZNF281 | |
| Interaction | SCN5A interactions | 3.17e-05 | 47 | 157 | 5 | int:SCN5A | |
| Interaction | CHD4 interactions | MYC NOLC1 MRE11 SETD1A SALL3 LEO1 TCOF1 KAT6A RSF1 NASP KRI1 ADAR HP1BP3 SGK3 UBE4A NOM1 FIP1L1 SCAF11 HDGFL2 ZNF687 | 4.25e-05 | 938 | 157 | 20 | int:CHD4 |
| Interaction | DNAJB6 interactions | MYC NOLC1 SP100 MAP1B BAG1 KRI1 MRTO4 QSER1 NOPCHAP1 HDGFL2 HSP90AA1 NOL8 | 4.33e-05 | 379 | 157 | 12 | int:DNAJB6 |
| Interaction | SRPK2 interactions | NOLC1 TCOF1 UBR4 KAT6A KRI1 ADAR HP1BP3 PNMA8B SETD2 FXR1 RRP9 NOM1 FIP1L1 MACF1 SCAF11 MRTO4 NOL8 | 4.58e-05 | 717 | 157 | 17 | int:SRPK2 |
| Interaction | APEX1 interactions | MYC NOLC1 ATP8B3 GPRASP1 GCFC2 GIT1 TCOF1 KTN1 KAT6A RSF1 E2F7 KRI1 PRDM4 ADAR PLEKHG5 HP1BP3 SETD2 FAM169A SCAF11 HDGFL2 NIPBL AFF4 NOL8 MGRN1 | 4.88e-05 | 1271 | 157 | 24 | int:APEX1 |
| Interaction | YY1AP1 interactions | 5.21e-05 | 52 | 157 | 5 | int:YY1AP1 | |
| Interaction | ALPK1 interactions | 5.35e-05 | 10 | 157 | 3 | int:ALPK1 | |
| Interaction | H1-4 interactions | MYC NOLC1 SP100 LEO1 TCOF1 RSF1 BAG1 KRI1 TSC22D2 PIAS1 HP1BP3 FXR1 NOM1 MACF1 SCAF11 TANC1 | 5.55e-05 | 656 | 157 | 16 | int:H1-4 |
| Interaction | PCGF6 interactions | 5.96e-05 | 171 | 157 | 8 | int:PCGF6 | |
| Interaction | DOT1L interactions | TCOF1 KTN1 ZNF629 TMOD3 KRI1 ADAR HP1BP3 ORC1 FXR1 RRP9 NOM1 FIP1L1 AFF1 SCAF11 MRTO4 ZNF687 HSP90AA1 NOL8 | 5.96e-05 | 807 | 157 | 18 | int:DOT1L |
| Interaction | CDK1 interactions | MYC CDKN3 NES LEO1 KAT6A RSF1 BAG1 NASP IRF2 APLP2 CCND2 ORC1 MRTO4 AFF4 HSP90AA1 | 6.03e-05 | 590 | 157 | 15 | int:CDK1 |
| Interaction | FGF12 interactions | 6.10e-05 | 87 | 157 | 6 | int:FGF12 | |
| Interaction | RAD18 interactions | NOLC1 MRE11 SETD1A LEO1 RSF1 TMOD3 AP3B1 HP1BP3 AFAP1 HLTF FIP1L1 SCAF11 HDGFL2 | 6.22e-05 | 457 | 157 | 13 | int:RAD18 |
| Interaction | DNAJC17 interactions | 8.74e-05 | 134 | 157 | 7 | int:DNAJC17 | |
| Interaction | NFKBIL1 interactions | 8.86e-05 | 93 | 157 | 6 | int:NFKBIL1 | |
| Interaction | RICTOR interactions | MYC SP100 GCFC2 MAP1B GIT1 KTN1 NACA TMOD3 NASP BCOR EPB41L3 TRIM66 FXR1 INF2 NOM1 NACA4P HSP90AA1 | 9.19e-05 | 759 | 157 | 17 | int:RICTOR |
| Interaction | MCRS1 interactions | 9.70e-05 | 235 | 157 | 9 | int:MCRS1 | |
| Interaction | SMC5 interactions | NOLC1 MRE11 SALL3 MAP1B KTN1 RSF1 KRI1 BCOR EPB41L3 ADAR HP1BP3 SETD2 FIP1L1 SCAF11 QSER1 HDGFL2 NIPBL AFF4 HSP90AA1 NOL8 | 1.02e-04 | 1000 | 157 | 20 | int:SMC5 |
| Interaction | DAXX interactions | MYC NOLC1 SETD1A SETD1B KRI1 PIAS1 HP1BP3 MACF1 PIBF1 HDGFL2 AFF4 | 1.05e-04 | 353 | 157 | 11 | int:DAXX |
| Interaction | PLCD4 interactions | 1.08e-04 | 32 | 157 | 4 | int:PLCD4 | |
| Interaction | YWHAH interactions | NOLC1 NES GIT1 BAD BAG1 ZNF629 SPIRE1 EPB41L3 PLEKHG5 ZNF106 FXR1 OSBPL5 MACF1 TANC1 CRYBG3 PPIP5K2 PATJ PIBF1 CFAP97 HSP90AA1 SPATA13 | 1.34e-04 | 1102 | 157 | 21 | int:YWHAH |
| Interaction | H3C3 interactions | MIER2 PHF12 RSF1 NASP PIAS1 HP1BP3 FAM169A HLTF SCAF11 QSER1 HDGFL2 NIPBL AFF4 | 1.38e-04 | 495 | 157 | 13 | int:H3C3 |
| Interaction | ARRB1 interactions | NOLC1 MAP1B TCOF1 KTN1 BAG1 TMOD3 AP3B1 HDGFL2 HSP90AA1 MGRN1 | 1.40e-04 | 304 | 157 | 10 | int:ARRB1 |
| Interaction | BRD2 interactions | MYC NOLC1 LEO1 RSF1 BAG1 GJD4 HP1BP3 DNAJC17 TANC1 QSER1 HDGFL2 ZNF687 | 1.40e-04 | 429 | 157 | 12 | int:BRD2 |
| Interaction | NIFK interactions | MYC NOLC1 LEO1 TCOF1 KAT6A KRI1 ADAR ZNF106 NOM1 MRTO4 AFF4 NOL8 | 1.47e-04 | 431 | 157 | 12 | int:NIFK |
| Interaction | IFI16 interactions | MYC SP100 MAP1B KTN1 E2F7 TMOD3 KRI1 ADAR HP1BP3 FXR1 INF2 RRP9 MRTO4 ZNF579 DTHD1 HSP90AA1 | 1.48e-04 | 714 | 157 | 16 | int:IFI16 |
| Interaction | CSNK2A2 interactions | MYC NOLC1 GCFC2 SPIB GIT1 TCOF1 KAT6A NACA BCOR EPB41L3 ZNF106 FIP1L1 HDGFL2 CFAP97 ZNF687 HSP90AA1 | 1.58e-04 | 718 | 157 | 16 | int:CSNK2A2 |
| Interaction | RTF1 interactions | 1.77e-04 | 150 | 157 | 7 | int:RTF1 | |
| Interaction | ZNF330 interactions | NOLC1 LEO1 RSF1 ZNF629 KRI1 HP1BP3 ZNF106 FAM169A HLTF NIPBL AFF4 NOL8 | 2.01e-04 | 446 | 157 | 12 | int:ZNF330 |
| Interaction | H2AX interactions | MRE11 MIER3 NACA RSF1 KRI1 BCOR PIAS1 UBE4A RRP9 HLTF HDGFL2 NIPBL ZNF687 HSP90AA1 | 2.30e-04 | 593 | 157 | 14 | int:H2AX |
| Interaction | YWHAZ interactions | MYC NOLC1 PDE1A GIT1 KAT6A BAD RSF1 ZNF629 SPIRE1 BCOR EPB41L3 AP3B1 PLEKHG5 PIAS1 MAP3K4 PLEKHO2 MACF1 C3 SCAF11 TANC1 PPIP5K2 HSP90AA1 SPATA13 | 2.31e-04 | 1319 | 157 | 23 | int:YWHAZ |
| Interaction | H3C1 interactions | SETD1A SETD1B LEO1 UBR4 KAT6A NACA RSF1 NASP KRI1 KDM6B PIAS1 HP1BP3 SETD2 DNAJC17 KDM4A HDGFL2 NIPBL AFF4 | 2.36e-04 | 901 | 157 | 18 | int:H3C1 |
| Interaction | SIRT7 interactions | NOLC1 MRE11 NES MAP1B TCOF1 UBR4 RSF1 KRI1 EPB41L3 HP1BP3 FXR1 RRP9 MACF1 SCAF11 MRTO4 NIPBL | 2.36e-04 | 744 | 157 | 16 | int:SIRT7 |
| Interaction | PIP4K2C interactions | 2.53e-04 | 159 | 157 | 7 | int:PIP4K2C | |
| Interaction | XRCC4 interactions | 2.71e-04 | 114 | 157 | 6 | int:XRCC4 | |
| Interaction | CTCF interactions | MYC SETD1A SP100 SALL3 MAP1B KTN1 KAT6A PRDM4 HP1BP3 FXR1 CELSR3 NOM1 | 2.72e-04 | 461 | 157 | 12 | int:CTCF |
| Interaction | AFF4 interactions | 2.84e-04 | 115 | 157 | 6 | int:AFF4 | |
| Interaction | CHD3 interactions | NOLC1 MRE11 GIT1 PHF12 KAT6A KRI1 BCOR ADAR PIAS1 HP1BP3 SGK3 FIP1L1 SCAF11 MRTO4 ZNF687 HSP90AA1 | 2.87e-04 | 757 | 157 | 16 | int:CHD3 |
| Interaction | KCNJ2 interactions | 3.15e-04 | 42 | 157 | 4 | int:KCNJ2 | |
| Interaction | FBXO22 interactions | MYC KTN1 NASP NBEA EPB41L3 MAP3K4 HP1BP3 ZNF106 SCN9A KDM4A HDGFL2 NACA4P ZNF687 | 3.21e-04 | 540 | 157 | 13 | int:FBXO22 |
| Interaction | CAMKV interactions | 3.26e-04 | 118 | 157 | 6 | int:CAMKV | |
| Interaction | XRCC6 interactions | MYC MRE11 MAP1B BAG1 TMOD3 NASP KRI1 IRF2 ADAR PIAS1 ORC1 CYREN RNF146 SCAF11 HDGFL2 AFF4 HSP90AA1 NOL8 | 3.37e-04 | 928 | 157 | 18 | int:XRCC6 |
| Interaction | FBXW11 interactions | MRE11 MAP1B NACA PHTF2 SPIRE1 BCOR ADAR PLEKHG5 SBF2 HLTF TANC1 HSP90AA1 | 3.43e-04 | 473 | 157 | 12 | int:FBXW11 |
| Interaction | TERF2 interactions | MRE11 SP100 TCOF1 KAT6A NASP PIAS1 ORC1 MACF1 HDGFL2 HSP90AA1 | 3.43e-04 | 340 | 157 | 10 | int:TERF2 |
| Interaction | PML interactions | MYC NOLC1 SP100 MAP1B KAT6A TMOD3 ARMCX2 BCOR EPB41L3 PIAS1 HP1BP3 TRIM66 ZNF106 FXR1 DNAJC17 FIP1L1 MRTO4 ZNF687 | 3.59e-04 | 933 | 157 | 18 | int:PML |
| Interaction | ING4 interactions | 3.59e-04 | 78 | 157 | 5 | int:ING4 | |
| Interaction | NUP43 interactions | SETD1A SETD1B LEO1 SZT2 PHF12 RSF1 KRI1 BCOR HP1BP3 SETD2 FAM169A HLTF NIPBL ZNF687 | 3.91e-04 | 625 | 157 | 14 | int:NUP43 |
| Interaction | FOXK2 interactions | 3.92e-04 | 225 | 157 | 8 | int:FOXK2 | |
| Interaction | MLLT1 interactions | 4.08e-04 | 123 | 157 | 6 | int:MLLT1 | |
| Interaction | SIRT6 interactions | SETD1A SETD1B GIT1 TCOF1 BCOR ADAR PIAS1 MAP3K4 SETD2 FXR1 CELSR3 RRP9 FIP1L1 ZNF687 | 4.11e-04 | 628 | 157 | 14 | int:SIRT6 |
| Interaction | MECP2 interactions | MYC NOLC1 NES SP100 MAP1B TCOF1 ZNF629 TMOD3 APLP2 EPB41L3 ADAR HP1BP3 SETD2 AFAP1 MKX FIP1L1 MACF1 PPIP5K2 NIPBL AFF4 HSP90AA1 NOL8 | 4.20e-04 | 1287 | 157 | 22 | int:MECP2 |
| Interaction | POLR1E interactions | 4.31e-04 | 350 | 157 | 10 | int:POLR1E | |
| Interaction | HMGB1 interactions | MYC MRE11 SP100 MAP1B RSF1 NASP IRF2 HP1BP3 KCNJ2 FIP1L1 C3 HSP90AA1 | 4.37e-04 | 486 | 157 | 12 | int:HMGB1 |
| Interaction | CBX1 interactions | 4.39e-04 | 288 | 157 | 9 | int:CBX1 | |
| Interaction | PATJ interactions | 4.44e-04 | 125 | 157 | 6 | int:PATJ | |
| Interaction | POLR1G interactions | MYC NOLC1 LEO1 TCOF1 UBR4 KAT6A RSF1 KRI1 ZNF106 NIPBL AFF4 NOL8 | 4.62e-04 | 489 | 157 | 12 | int:POLR1G |
| Interaction | USP14 interactions | MYC MRE11 MAP1B NACA BAG1 TMOD3 HP1BP3 FXR1 ATAD1 MACF1 PATJ HDGFL2 | 4.62e-04 | 489 | 157 | 12 | int:USP14 |
| Interaction | KCNA3 interactions | MRE11 AFF2 MAP1B ZFYVE16 TCOF1 SZT2 KTN1 NACA TMOD3 EPB41L3 AP3B1 ORC1 KCNE4 MACF1 CRYBG3 PATJ HSP90AA1 | 4.62e-04 | 871 | 157 | 17 | int:KCNA3 |
| Interaction | SNRNP40 interactions | MYC GCFC2 TCOF1 PHF12 KAT6A RSF1 KRI1 BCOR SETD2 DNAJC17 HLTF SCAF11 HDGFL2 NOL8 | 4.73e-04 | 637 | 157 | 14 | int:SNRNP40 |
| Interaction | FBXW7 interactions | MYC MRE11 GIT1 KTN1 UBR4 TMOD3 ADAR HP1BP3 FXR1 CEP78 RRP9 NOM1 RNF146 SBF2 MACF1 C3 SCAF11 MRTO4 HDGFL2 MAGEC2 HSP90AA1 | 4.97e-04 | 1215 | 157 | 21 | int:FBXW7 |
| Interaction | PRDM1 interactions | 5.06e-04 | 84 | 157 | 5 | int:PRDM1 | |
| Interaction | PYHIN1 interactions | MRE11 MAP1B TCOF1 RSF1 KRI1 APLP2 HP1BP3 MRTO4 HDGFL2 ZNF687 | 5.14e-04 | 358 | 157 | 10 | int:PYHIN1 |
| Interaction | MLLT3 interactions | 5.35e-04 | 85 | 157 | 5 | int:MLLT3 | |
| Interaction | NOP56 interactions | MYC NOLC1 LEO1 TCOF1 KRI1 BCOR ZNF106 FXR1 RRP9 NOM1 MRTO4 AFF4 NOL8 | 5.36e-04 | 570 | 157 | 13 | int:NOP56 |
| Interaction | SLX4 interactions | MRE11 NACA ZNF629 BCOR AP3B1 ADAR PIAS1 ZNF106 NIPBL AFF4 ZNF687 HSP90AA1 NOL8 | 5.53e-04 | 572 | 157 | 13 | int:SLX4 |
| Interaction | FLNA interactions | MYC MAP1B KAT6A TMOD3 KDM6B PIAS1 FXR1 KCNE4 AFAP1 INF2 KCNJ2 PATJ NIPBL HSP90AA1 | 5.60e-04 | 648 | 157 | 14 | int:FLNA |
| Interaction | MKI67 interactions | MYC MRE11 SETD1A MAP1B TCOF1 KRI1 ADAR ZNF106 OSBPL5 FIP1L1 SCAF11 MRTO4 QSER1 NIPBL | 5.60e-04 | 648 | 157 | 14 | int:MKI67 |
| Interaction | PARP1 interactions | MYC NOLC1 MRE11 SETD1A LEO1 RSF1 BAG1 KRI1 IRF2 ADAR PIAS1 HP1BP3 ZNF106 RNF146 FAM169A HLTF FIP1L1 SCAF11 HDGFL2 NIPBL AFF4 NOL8 | 5.68e-04 | 1316 | 157 | 22 | int:PARP1 |
| Interaction | SENP1 interactions | 5.70e-04 | 131 | 157 | 6 | int:SENP1 | |
| Interaction | GRK5 interactions | 5.70e-04 | 182 | 157 | 7 | int:GRK5 | |
| Interaction | PPIA interactions | MYC MRE11 NES SP100 SALL3 MAP1B ZFYVE16 NACA ADAR PIAS1 DNAJC17 AFAP1 MACF1 TANC1 CRYBG3 HDGFL2 ZNF687 | 5.74e-04 | 888 | 157 | 17 | int:PPIA |
| Interaction | H2BC8 interactions | MIER3 RSF1 ZNF629 BCOR PIAS1 HP1BP3 DNAJC17 FAM169A SCAF11 QSER1 HDGFL2 NIPBL ZNF687 | 5.90e-04 | 576 | 157 | 13 | int:H2BC8 |
| Cytoband | 12q23-q24.1 | 1.79e-04 | 6 | 160 | 2 | 12q23-q24.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.54e-07 | 9 | 109 | 4 | 1203 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 8.49e-07 | 4 | 109 | 3 | 1145 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.74e-05 | 9 | 109 | 3 | 1280 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.04e-05 | 34 | 109 | 4 | 487 | |
| GeneFamily | PHD finger proteins | 2.12e-04 | 90 | 109 | 5 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.00e-04 | 181 | 109 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 109 | 6 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 3.48e-03 | 242 | 109 | 6 | 403 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.62e-03 | 17 | 109 | 2 | 1197 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MRE11 SP100 LEO1 RSF1 E2F7 TMOD3 IRAK2 SPIRE1 TSC22D2 FXR1 CELSR3 MKX QSER1 NIPBL MAGEC2 AFF4 HSP90AA1 NOL8 | 3.55e-07 | 721 | 157 | 18 | M10237 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC SP100 MAP1B ZFYVE16 KAT6A TSC22D2 AP3B1 MAP3K4 SETD2 FXR1 AFAP1 FAM169A HLTF AFF1 MACF1 CRYBG3 PPIP5K2 PIBF1 NIPBL | 9.65e-07 | 856 | 157 | 19 | M4500 |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 3.50e-06 | 200 | 157 | 9 | M5055 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 7.31e-06 | 219 | 157 | 9 | M41199 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | MRE11 SZT2 UBR4 BAD RSF1 MYRIP NASP APLP2 HP1BP3 HIVEP3 UBE4A SETD2 AFAP1 ATAD1 MACF1 KDM4A FAM149B1 | 7.44e-06 | 807 | 157 | 17 | M14594 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 7.50e-06 | 166 | 157 | 8 | M344 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 2.16e-05 | 192 | 157 | 8 | M8272 | |
| Coexpression | HALLMARK_MYC_TARGETS_V2 | 2.57e-05 | 58 | 157 | 5 | M5928 | |
| Coexpression | KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN | 4.43e-05 | 33 | 157 | 4 | M2106 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | KTN1 KAT6A MIER3 IRF2 RFFL CCND2 SGK3 AREL1 AFF1 TANC1 SPATA13 | 4.64e-05 | 418 | 157 | 11 | M12676 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 5.67e-05 | 162 | 157 | 7 | M7002 | |
| Coexpression | TBK1.DF_DN | 5.98e-05 | 286 | 157 | 9 | M2864 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | KTN1 KAT6A MIER3 IRF2 RFFL CCND2 SGK3 AREL1 AFF1 TANC1 SPATA13 | 6.63e-05 | 435 | 157 | 11 | MM1221 |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 9.22e-05 | 175 | 157 | 7 | M2940 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MYC NOLC1 MRE11 SETD1A MAGEA9 SP100 GCFC2 AFF2 TCOF1 NACA LAIR1 PHTF2 NASP IRF2 AP3B1 ADAR SCAF11 KDM4A PPIP5K2 LY9 PIBF1 | 9.23e-05 | 1394 | 157 | 21 | M9585 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MYC NOLC1 ZFYVE16 PHF12 NACA TSC22D2 BCOR SFMBT2 HP1BP3 CCND2 AFAP1 SBF2 KANK4 FIP1L1 KCNS3 MRTO4 SPATA13 | 1.22e-04 | 1009 | 157 | 17 | M157 |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP | 1.44e-04 | 83 | 157 | 5 | M15537 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | ATP8B3 MRE11 AFF2 SZT2 KTN1 UBR4 KAT6A APLP2 EPB41L3 TRIM66 ZNF106 INF2 KCNJ2 AFF1 | 1.67e-04 | 746 | 157 | 14 | M40863 |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP | 1.92e-04 | 197 | 157 | 7 | M4993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL | 1.96e-04 | 48 | 157 | 4 | M45762 | |
| Coexpression | GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 1.98e-04 | 198 | 157 | 7 | M3267 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.04e-04 | 199 | 157 | 7 | M7254 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 2.04e-04 | 199 | 157 | 7 | M3800 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 2.10e-04 | 200 | 157 | 7 | M3377 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | 2.10e-04 | 200 | 157 | 7 | M3236 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.10e-04 | 200 | 157 | 7 | M9889 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN | 2.10e-04 | 200 | 157 | 7 | M9848 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP | 2.10e-04 | 200 | 157 | 7 | M3840 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.10e-04 | 200 | 157 | 7 | M6611 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GPRASP1 PDE1A PDE1C MAP1B MYRIP NBEA HIVEP3 CSRNP3 SCN8A SCN9A FAM169A HS3ST4 | 2.18e-04 | 584 | 157 | 12 | M39068 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | LEO1 MAP1B KTN1 RSF1 E2F7 NASP SPIRE1 TSC22D2 PIAS1 MAP3K4 ZNF106 FXR1 KCNT2 FAM169A SCAF11 PIBF1 NIPBL NOL8 | 9.55e-08 | 532 | 158 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | PPP1R21 CDKN3 AFF2 NASP RFFL AP3B1 UBE4A MACF1 SCAF11 ZNF579 NIPBL AFF4 | 1.95e-06 | 291 | 158 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.13e-06 | 204 | 158 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 NES GCFC2 AFF2 LEO1 MAP1B TCOF1 KTN1 RSF1 E2F7 NASP SPIRE1 XK ORC1 PRDM9 KCNT2 SCN8A FAM169A FIP1L1 MACF1 SCAF11 QSER1 FAM149B1 PIBF1 NIPBL CFAP97 HSP90AA1 NOL8 | 3.27e-06 | 1459 | 158 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 CDKN3 NES SP100 SALL3 MAP1B TCOF1 KTN1 NASP POU3F4 RFFL AP3B1 ORC1 SETD2 AFAP1 FAM169A ZNF579 PIBF1 NIPBL HSP90AA1 SPATA13 NOL8 | 4.30e-06 | 989 | 158 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CDKN3 GCFC2 BAG1 NASP RFFL AP3B1 HP1BP3 UBE4A SETD2 AFAP1 RNF146 MACF1 SCAF11 KDM4A FAM149B1 ZNF579 NIPBL CFAP97 AFF4 | 5.74e-06 | 780 | 158 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 GCFC2 LEO1 TCOF1 KTN1 RSF1 E2F7 NASP SPIRE1 XK ORC1 PRDM9 KCNT2 SCN8A FAM169A FIP1L1 MACF1 SCAF11 QSER1 FAM149B1 PIBF1 NIPBL CFAP97 HSP90AA1 NOL8 | 6.44e-06 | 1257 | 158 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NES PDE1C SGSM1 GCFC2 AFF2 MAP1B PHF12 KTN1 RSF1 MYRIP E2F7 PHTF2 NASP XK BCOR ORC1 PRDM9 KCNT2 CEP78 SCN8A FAM169A FIP1L1 ZNF579 NIPBL HSP90AA1 SPATA13 | 9.44e-06 | 1370 | 158 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 1.32e-05 | 145 | 158 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | PPP1R21 CDKN3 SP100 SGSM1 AFF2 SZT2 BAD NASP IRAK2 POU3F4 RFFL AP3B1 HP1BP3 UBE4A KANK4 MACF1 SCAF11 TANC1 ZNF579 NIPBL AFF4 | 1.38e-05 | 985 | 158 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | NES SP100 SGSM1 AFF2 MAP1B KTN1 NASP XK BCOR HIVEP3 PRDM9 CEP78 CSRNP3 KCNJ2 SCN9A MACF1 SCAF11 ZNF579 PIBF1 NIPBL SPATA13 | 1.40e-05 | 986 | 158 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 NES MAP1B TCOF1 KTN1 RSF1 NASP POU3F4 ORC1 KCNT2 FAM169A HSP90AA1 SPATA13 NOL8 | 2.13e-05 | 496 | 158 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.70e-05 | 271 | 158 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 4.02e-05 | 124 | 158 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.73e-05 | 182 | 158 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.78e-05 | 192 | 158 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SP100 AFF2 TCOF1 KTN1 KAT6A BAD NASP IRAK2 AP3B1 ZFAND4 CCND2 UBE4A KCNJ2 FAM169A KANK4 MACF1 QSER1 ZNF579 NIPBL | 1.45e-04 | 989 | 158 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 NES MAP1B TCOF1 KTN1 RSF1 NASP POU3F4 ORC1 ZNF106 FXR1 KCNT2 CEP78 RRP9 FAM169A SCAF11 HSP90AA1 SPATA13 NOL8 | 1.48e-04 | 991 | 158 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PPP1R21 CDKN3 GCFC2 MAP1B KTN1 NASP RFFL AP3B1 SETD2 AFAP1 RNF146 FAM149B1 ZNF579 PIBF1 NIPBL AFF4 NOL8 | 1.58e-04 | 831 | 158 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PDE1A PHF12 KTN1 KAT6A BAD NASP AP3B1 ZFAND4 UBE4A FAM169A MACF1 QSER1 ZNF579 NIPBL | 2.64e-04 | 629 | 158 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 PDE1A SALL3 KTN1 NASP XK ORC1 FAM169A ZNF579 HSP90AA1 SPATA13 NOL8 | 3.07e-04 | 489 | 158 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | SP100 BAD NASP IRAK2 AP3B1 UBE4A KANK4 MACF1 SCAF11 TANC1 ZNF579 NIPBL | 3.25e-04 | 492 | 158 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | MIER2 NES SP100 GCFC2 AFF2 MAP1B MYRIP E2F7 NASP XK ORC1 PRDM9 SCN8A FAM169A FIP1L1 MACF1 QSER1 ZNF579 NIPBL HSP90AA1 SPATA13 NOL8 TJP3 | 3.26e-04 | 1414 | 158 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MIER2 GCFC2 MAP1B MYRIP E2F7 NASP XK ORC1 PRDM9 SCN8A FAM169A FIP1L1 MACF1 QSER1 ZNF579 NIPBL HSP90AA1 SPATA13 NOL8 | 3.47e-04 | 1060 | 158 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | NES SALL3 MAP1B KTN1 NASP POU3F4 FAM169A PIBF1 NIPBL HSP90AA1 SPATA13 NOL8 | 3.62e-04 | 498 | 158 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PDE1A LEO1 MAP1B KTN1 NASP SPIRE1 NBEA ZFAND4 PRDM9 OSBPL5 FAM169A ANKRD12 ZNF579 NOL8 | 3.91e-04 | 654 | 158 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.31e-04 | 130 | 158 | 6 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.96e-04 | 186 | 158 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DOCK8 KTN1 KAT6A RSF1 HP1BP3 ZNF106 SETD2 MACF1 SCAF11 NIPBL | 1.29e-09 | 184 | 159 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-08 | 185 | 159 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.53e-08 | 200 | 159 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-07 | 176 | 159 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.09e-07 | 199 | 159 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.09e-07 | 199 | 159 | 8 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-07 | 200 | 159 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.33e-07 | 200 | 159 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.71e-06 | 159 | 159 | 7 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.47e-06 | 168 | 159 | 7 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 182 | 159 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 185 | 159 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.01e-06 | 187 | 159 | 7 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.76e-06 | 191 | 159 | 7 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.96e-06 | 192 | 159 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.96e-06 | 192 | 159 | 7 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.17e-06 | 193 | 159 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.17e-06 | 193 | 159 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-06 | 194 | 159 | 7 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.60e-06 | 195 | 159 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.60e-06 | 195 | 159 | 7 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.60e-06 | 195 | 159 | 7 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 7.53e-06 | 199 | 159 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.53e-06 | 199 | 159 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-06 | 199 | 159 | 7 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.53e-06 | 199 | 159 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 3.15e-05 | 168 | 159 | 6 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.26e-05 | 169 | 159 | 6 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 171 | 159 | 6 | fea6ef6bbfebea2dd0f0360c7db7a5e858f15958 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 171 | 159 | 6 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 171 | 159 | 6 | f15594fd4d709920733de9376a391dedc62b65de | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-05 | 173 | 159 | 6 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.84e-05 | 174 | 159 | 6 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 175 | 159 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-05 | 177 | 159 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.22e-05 | 177 | 159 | 6 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.22e-05 | 177 | 159 | 6 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 178 | 159 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.36e-05 | 178 | 159 | 6 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 179 | 159 | 6 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 179 | 159 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 180 | 159 | 6 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 182 | 159 | 6 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 182 | 159 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 182 | 159 | 6 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.73e-05 | 187 | 159 | 6 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 188 | 159 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.90e-05 | 188 | 159 | 6 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 189 | 159 | 6 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 189 | 159 | 6 | af391c321753743709e2da01a5aa7782d8cc54e3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.08e-05 | 189 | 159 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 6.26e-05 | 190 | 159 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-05 | 190 | 159 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.26e-05 | 190 | 159 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.63e-05 | 192 | 159 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 6.63e-05 | 192 | 159 | 6 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 192 | 159 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.63e-05 | 192 | 159 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-05 | 192 | 159 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.83e-05 | 193 | 159 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | Control-B_naive-13|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.83e-05 | 193 | 159 | 6 | 32e53a6473a682cf14b20a399c3686f658298b93 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.83e-05 | 193 | 159 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.83e-05 | 193 | 159 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.02e-05 | 194 | 159 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 7.02e-05 | 194 | 159 | 6 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-05 | 194 | 159 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 7.22e-05 | 195 | 159 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 7.43e-05 | 196 | 159 | 6 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.43e-05 | 196 | 159 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.43e-05 | 196 | 159 | 6 | d08f6143d148a897efacc854e4306455a9a9868c | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 197 | 159 | 6 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-pDC|Influenza_Severe / Disease, condition lineage and cell class | 7.64e-05 | 197 | 159 | 6 | e8e6f71e6dc8a695e4321a18543c1df63dd62f3e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.64e-05 | 197 | 159 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 7.64e-05 | 197 | 159 | 6 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 197 | 159 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.64e-05 | 197 | 159 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.64e-05 | 197 | 159 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.86e-05 | 198 | 159 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.86e-05 | 198 | 159 | 6 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 7.86e-05 | 198 | 159 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 199 | 159 | 6 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 8.08e-05 | 199 | 159 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.08e-05 | 199 | 159 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.08e-05 | 199 | 159 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.08e-05 | 199 | 159 | 6 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 8.08e-05 | 199 | 159 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | CV-Mild-2|Mild / Virus stimulation, Condition and Cluster | 8.08e-05 | 199 | 159 | 6 | d88cc07053a852e6c468538a0a851ffa09f97a0d | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.08e-05 | 199 | 159 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.31e-05 | 200 | 159 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.31e-05 | 200 | 159 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.31e-05 | 200 | 159 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 8.31e-05 | 200 | 159 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.31e-05 | 200 | 159 | 6 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.60e-05 | 65 | 159 | 4 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.60e-05 | 65 | 159 | 4 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | GPRASP1 ZFYVE16 UBR4 ZNF629 ZNF106 FAM169A AFF1 MACF1 SCAF11 ANKRD12 | 8.78e-07 | 191 | 157 | 10 | 4168_DN |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.22e-06 | 198 | 157 | 10 | 6271_DN | |
| Drug | Lidocaine | 1.28e-06 | 4 | 157 | 3 | DB00281 | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | 9.51e-06 | 197 | 157 | 9 | 2034_DN | |
| Drug | geldanamycin | NES MAP1B KAT6A PHTF2 TMOD3 NASP BCOR CCND2 SETD2 NIPBL AFF4 HSP90AA1 | 1.07e-05 | 371 | 157 | 12 | ctd:C001277 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.35e-07 | 10 | 151 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.35e-07 | 10 | 151 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.16e-07 | 12 | 151 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 2.60e-05 | 2 | 151 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | stomach carcinoma (is_implicated_in) | 2.79e-05 | 12 | 151 | 3 | DOID:5517 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | MRE11 KTN1 UBR4 BAG1 EPB41L3 ADAR FSCB SGK3 SETD2 FXR1 KCNT2 RRP9 AFF1 MACF1 NIPBL MAGEC2 HSP90AA1 | 3.80e-05 | 1074 | 151 | 17 | C0006142 |
| Disease | B Virus Infection | 7.78e-05 | 3 | 151 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 7.78e-05 | 3 | 151 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.78e-05 | 3 | 151 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 7.78e-05 | 3 | 151 | 2 | C0014805 | |
| Disease | complement C3 measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0004983 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 7.78e-05 | 3 | 151 | 2 | C1833661 | |
| Disease | Brugada ECG Pattern | 1.55e-04 | 4 | 151 | 2 | C1721096 | |
| Disease | Adenoid Cystic Carcinoma | 1.67e-04 | 100 | 151 | 5 | C0010606 | |
| Disease | epilepsy (implicated_via_orthology) | 1.99e-04 | 163 | 151 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | body fat percentage | PPP1R21 PDE1C PHTF2 TSC22D2 PIAS1 HIVEP3 TRIM66 MACF1 KCNS3 PATJ | 2.19e-04 | 488 | 151 | 10 | EFO_0007800 |
| Disease | colorectal cancer | PPP1R21 CDKN3 PDE1C PIAS1 CCND2 SBF2 MACF1 KCNS3 TANC1 HS3ST4 MYO16 | 2.93e-04 | 604 | 151 | 11 | MONDO_0005575 |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 3.85e-04 | 6 | 151 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | MAP1B SZT2 KTN1 TSC22D2 HP1BP3 ZNF106 ZNF469 AFAP1 LRRIQ1 MKX AFF1 MACF1 KCNS3 QSER1 MYO16 | 4.03e-04 | 1069 | 151 | 15 | EFO_0004346 |
| Disease | dental caries | 4.16e-04 | 187 | 151 | 6 | EFO_0003819 | |
| Disease | electrocardiography, PR interval | 5.37e-04 | 7 | 151 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 5.37e-04 | 7 | 151 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 5.37e-04 | 7 | 151 | 2 | C0020075 | |
| Disease | facial hair thickness measurement | 5.84e-04 | 32 | 151 | 3 | EFO_0007823 | |
| Disease | Embryonal Rhabdomyosarcoma | 7.14e-04 | 8 | 151 | 2 | C0206656 | |
| Disease | Burkitt Lymphoma | 8.29e-04 | 36 | 151 | 3 | C0006413 | |
| Disease | supraventricular ectopy | 9.15e-04 | 9 | 151 | 2 | EFO_0009277 | |
| Disease | Colorectal Carcinoma | MYC SALL3 MAP1B TCOF1 GJD4 CCND2 HIVEP3 CYREN ATAD1 CSRNP3 IQUB | 1.01e-03 | 702 | 151 | 11 | C0009402 |
| Disease | Carotid Circulation Transient Ischemic Attack | 1.14e-03 | 10 | 151 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 1.14e-03 | 10 | 151 | 2 | C0007787 | |
| Disease | Crescendo Transient Ischemic Attacks | 1.14e-03 | 10 | 151 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 1.14e-03 | 10 | 151 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 1.14e-03 | 10 | 151 | 2 | C0751022 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 1.14e-03 | 10 | 151 | 2 | C0472381 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 1.14e-03 | 10 | 151 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 1.14e-03 | 10 | 151 | 2 | C0917805 | |
| Disease | Neurodevelopmental Disorders | 1.35e-03 | 93 | 151 | 4 | C1535926 | |
| Disease | Tachycardia, Ventricular | 1.39e-03 | 11 | 151 | 2 | C0042514 | |
| Disease | Shortened QT interval | 1.39e-03 | 11 | 151 | 2 | C0151879 | |
| Disease | waist circumference | 1.71e-03 | 429 | 151 | 8 | EFO_0004342 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.90e-03 | 102 | 151 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Brugada Syndrome 1 | 1.96e-03 | 13 | 151 | 2 | C4551804 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.04e-03 | 49 | 151 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | body weight | PDE1A PDE1C BAD E2F7 TSC22D2 AP3B1 PRDM4 CCND2 SGK3 TRIM66 SETD2 KCNE4 MKX PATJ NIPBL | 2.11e-03 | 1261 | 151 | 15 | EFO_0004338 |
| Disease | Intellectual Disability | 2.20e-03 | 447 | 151 | 8 | C3714756 | |
| Disease | T wave morphology measurement | 2.27e-03 | 14 | 151 | 2 | EFO_0008398 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 2.27e-03 | 14 | 151 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | disease recurrence, colon carcinoma | 2.29e-03 | 51 | 151 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 2.31e-03 | 352 | 151 | 7 | EFO_0007015 | |
| Disease | testosterone measurement | ATP8B3 ZNF629 TSC22D2 KDM6B ADAR CCND2 UBE4A SBF2 AFF1 MACF1 KCNS3 HS3ST4 MUCL3 MYO16 MGRN1 | 2.34e-03 | 1275 | 151 | 15 | EFO_0004908 |
| Disease | Epilepsy | 2.42e-03 | 109 | 151 | 4 | C0014544 | |
| Disease | African Burkitt's lymphoma | 2.61e-03 | 15 | 151 | 2 | C0343640 | |
| Disease | P wave duration | 2.61e-03 | 15 | 151 | 2 | EFO_0005094 | |
| Disease | Burkitt Leukemia | 2.61e-03 | 15 | 151 | 2 | C4721444 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.78e-03 | 364 | 151 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Neuralgia, Supraorbital | 2.98e-03 | 16 | 151 | 2 | C0038870 | |
| Disease | Neuralgia | 2.98e-03 | 16 | 151 | 2 | C0027796 | |
| Disease | Romano-Ward Syndrome | 2.98e-03 | 16 | 151 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 2.98e-03 | 16 | 151 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.98e-03 | 16 | 151 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.98e-03 | 16 | 151 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.98e-03 | 16 | 151 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 2.98e-03 | 16 | 151 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.98e-03 | 16 | 151 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.98e-03 | 16 | 151 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.98e-03 | 16 | 151 | 2 | C0042656 | |
| Disease | biliary atresia | 2.99e-03 | 56 | 151 | 3 | MONDO_0008867 | |
| Disease | triacylglycerol 56:9 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010436 | |
| Disease | PR interval | 4.09e-03 | 495 | 151 | 8 | EFO_0004462 | |
| Disease | Brugada syndrome | 4.20e-03 | 19 | 151 | 2 | MONDO_0015263 | |
| Disease | Malignant Neoplasms | 4.30e-03 | 128 | 151 | 4 | C0006826 | |
| Disease | QRS duration | 4.43e-03 | 298 | 151 | 6 | EFO_0005055 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EESEDTVTDVSPLST | 246 | Q9P2B7 | |
| DDSSQEDILSSEVSP | 2091 | Q68DQ2 | |
| EFEPSEQEDSSSAER | 6 | Q92934 | |
| VEEETTSTPTREDSS | 1231 | Q8N7X0 | |
| STDEQTSSAEEDVPT | 336 | Q8N556 | |
| ESSTTDSESNEAPRV | 501 | P51816 | |
| ASSPQSSDVEDEVED | 651 | P54840 | |
| DLSDQVPDTESETRI | 966 | P01024 | |
| EVTRDEESTRSEEVT | 121 | Q99933 | |
| VASDEDTDQEPLRST | 386 | Q9Y2X7 | |
| VSSDIASESLDPSDE | 1276 | O60423 | |
| TVESPSSSEVEEVDD | 426 | Q5JTW2 | |
| ISPSRNEERDSDTDS | 66 | Q6UB98 | |
| DSSHTETTAEEVPED | 1141 | Q6W2J9 | |
| TDTESDSDSEPETQR | 346 | Q7L311 | |
| RVSLDQDVETETEPS | 546 | Q96QP1 | |
| REIIETDTSSSDSDE | 641 | Q9UHB7 | |
| DSESESEPESESESR | 781 | O00203 | |
| EPDISSEESVSTVEE | 66 | Q5SSJ5 | |
| QQPVESSEDSSDESD | 316 | Q14978 | |
| SATNLESEEDSEAPV | 981 | Q2KHR3 | |
| ESEEDSEAPVDSTLN | 986 | Q2KHR3 | |
| AESETTDSVPSDEES | 231 | P14316 | |
| EEDDSENGVPESTST | 386 | P63252 | |
| SEDELDQASTPTDVR | 271 | P30279 | |
| ETPVDVRVSSEESEE | 581 | Q06481 | |
| SSSACSRSPEEEEEE | 131 | Q9BWK5 | |
| DELEETSETPLNESS | 196 | Q8WWG9 | |
| AIASDSEADSDTEVP | 291 | Q8WVC0 | |
| ANIDSEDESETIPTD | 2176 | P46821 | |
| EGSSSQEEEEPSSSV | 81 | P43362 | |
| VDSASPVEDTSNDES | 186 | Q8TC57 | |
| PTDEEEEEASSASST | 31 | Q9UBF1 | |
| PEETDDVDNSSLDAS | 526 | O43187 | |
| EAQSPLSEETSAEEA | 541 | Q5H9T9 | |
| DDDVSVSDESELPTS | 1081 | Q86WG5 | |
| DDPSTSEITSETQDR | 1711 | Q9Y6X6 | |
| SNPSETESERKDELS | 406 | P51114 | |
| SSPESFITEEVDESS | 491 | O60291 | |
| TEDVSQASPSESEAR | 71 | Q6GTX8 | |
| KESEDEESEEPDSTT | 1296 | O15054 | |
| PDEDESEVTSSASEK | 291 | Q96KN9 | |
| TQSLAPSESDEEEEE | 361 | Q8WYN3 | |
| SNEFEEELVSPSSSE | 256 | Q8IYA7 | |
| DTEDELSDIQTDSVP | 76 | P54750 | |
| TEDELSDIQSDAVPS | 86 | Q14123 | |
| PKVTETEDDSDSDSD | 76 | Q6UN15 | |
| KENESSDSEEEVSRP | 2486 | Q6KC79 | |
| ETESQDSAEPSGSEE | 1486 | P48681 | |
| SDDETSEQLTPEEEA | 616 | O75164 | |
| VIENSDVSPETESSE | 1306 | Q86UP2 | |
| SSESDSSDERVEFDP | 46 | Q8N9T8 | |
| TASSSDSEEDPEALE | 91 | Q8N9T8 | |
| VVSDPDSTDASSIED | 461 | Q9BQ31 | |
| LLSDQSEDETTPDEE | 646 | Q6UVM3 | |
| DDEETQSSADDLTPS | 116 | Q7Z3K6 | |
| DPRLQDSSSEEEDVT | 1076 | Q76FK4 | |
| EEDVTEETDHRNSSP | 1086 | Q76FK4 | |
| RTSDSEVPDVESRED | 651 | Q6ZMI0 | |
| SVSPSEEENSESSSE | 181 | Q7Z4V5 | |
| EEDTAPESALDTSLD | 1176 | Q27J81 | |
| AEESPEVTTEAAEAS | 341 | P49321 | |
| ETQSDDSDTDSVELP | 36 | Q96JM4 | |
| TVETEDSSVENPEQD | 2071 | Q9UPN3 | |
| QDHSDEETPTSDELE | 181 | P49335 | |
| STTSAASPEEEEESE | 36 | Q9UHY1 | |
| NDIFVRTSEDEPESS | 696 | Q9UMZ3 | |
| TEIDEASASSEPEEA | 131 | P09067 | |
| SQEESPEEDTERTER | 6 | Q9NQV7 | |
| LPAAEISDSSSDEEE | 411 | Q13415 | |
| TTEVLDEPFEDSDSE | 1041 | Q92794 | |
| SERDDRSSEAPATVE | 571 | Q96AV8 | |
| EESVVSEDTLSPDED | 1701 | Q8NF50 | |
| SLEPEDRNSTSVSED | 226 | P55265 | |
| DETTRSDISERPSVD | 601 | O14523 | |
| SDISERPSVDDIESE | 606 | O14523 | |
| EGSESRTLDVSTDEE | 86 | P16383 | |
| DVLEETSEPESSSEQ | 21 | A6NGH7 | |
| SSQRRPSTAVDEEDE | 321 | O15033 | |
| TETEIQETSESPREE | 121 | Q6ZMT9 | |
| ESEEEEESRSTRTLE | 111 | Q9NVM6 | |
| STARPSESSEEFLEE | 371 | Q9Y6X4 | |
| AELEEENSPAESESS | 206 | Q8TDB4 | |
| SSDSNLTTEEDEDRP | 536 | Q9HBG7 | |
| STEESDDAFDTVTIP | 16 | Q8NA54 | |
| SSEETSGEDSTPEDL | 676 | Q5T7N3 | |
| LEEPEDAEVFTESSS | 841 | Q9ULL0 | |
| ESSDSEEIETSELPQ | 396 | Q14527 | |
| DDPTADDTSAAVTEE | 701 | P07900 | |
| EEERSLSIPSSESED | 2901 | Q9NYQ7 | |
| EELVAVSDTAEDPSS | 26 | P0DP71 | |
| EELVAVSDTAEDPSS | 26 | A0A1B0GTK5 | |
| SIQTSEFDSSDEEPI | 6 | Q16667 | |
| DNSSRESPSLEDEET | 221 | Q96T23 | |
| VDEETAESDTSPVLE | 406 | Q99590 | |
| SSPSERAESEAAEEA | 101 | Q9BXA9 | |
| SDPSEDEDERSSQKL | 126 | Q96BR1 | |
| ASLDNDPSDSSEEET | 676 | Q9Y2J2 | |
| DPSDSSEEETDSERT | 681 | Q9Y2J2 | |
| LPEREAQESSTTDED | 156 | Q9Y661 | |
| EEETQSSADDLTPSV | 136 | Q8N344 | |
| DLPESASESTEESDS | 221 | Q9UKD2 | |
| TSSSSAPEEEEEDDS | 756 | Q9UKN5 | |
| GTPEESEKTEDSRTT | 241 | Q3MIW9 | |
| TPEILSDSEEDRVSS | 266 | Q6J4K2 | |
| SDKSERENPEESDTE | 301 | Q9H0X9 | |
| RENPEESDTETQDHS | 306 | Q9H0X9 | |
| DESNVAVTRPDSESS | 301 | Q96BN6 | |
| SSTDESEEEQISDPR | 456 | Q9Y6R4 | |
| SEDRELVNTDTESFP | 136 | Q5JY77 | |
| SESSIETEDLSEPEF | 1386 | Q5T011 | |
| QDSESARPESETEDV | 391 | Q8N3S3 | |
| ITEDTESLDDPDESR | 26 | O75157 | |
| ESLDDPDESRTEDVS | 31 | O75157 | |
| PDESRTEDVSSEIFD | 36 | O75157 | |
| PISTSESSEEEEEAE | 81 | Q13428 | |
| QSSSEESDSEEEAPA | 411 | Q13428 | |
| SSSSESEDEDVIPAT | 996 | Q13428 | |
| EDETQSIDSEDSFVP | 221 | Q8WZ73 | |
| PTITEEEFEDSLATD | 11 | Q8NE09 | |
| PTTSSDSEEEQEDEE | 246 | P01106 | |
| REIEDLSQSQSPESE | 1001 | Q8NFP9 | |
| SEEESEDTESEASEP | 511 | Q9ULN7 | |
| EDTESEASEPEDRAS | 516 | Q9ULN7 | |
| ASTETPTSEQNDVDE | 171 | Q96QT6 | |
| SVATEESTEPLSEDD | 1776 | Q14524 | |
| ATEESTEPLSEDDFE | 1766 | Q15858 | |
| PDTSIEETESDASSD | 281 | Q9NTX7 | |
| SEETEEEETSPQEES | 1456 | Q9C0D5 | |
| PETSSDEDLRSNSER | 786 | Q6ZUB0 | |
| LRPSTSVDEEDEESE | 981 | Q9UPS6 | |
| SPSSSEDEEEVVARE | 1171 | Q9UPS6 | |
| LPESDLESDSQDESE | 246 | Q5C9Z4 | |
| SSSDEEEEEPSAKRT | 466 | O75925 | |
| LDSPALEVSDSESDE | 136 | Q01892 | |
| VDESDVEEDIFPTTS | 646 | P49959 | |
| NSSESEDEDDSIPSE | 141 | Q8N5I9 | |
| LPAVEDSEATETSDE | 1271 | O15047 | |
| DSEATETSDEAERPR | 1276 | O15047 | |
| ESSSSDSEENEPLET | 486 | P51825 | |
| NSTSEESHDEDEIRP | 316 | Q8NBU5 | |
| SENSSSTPSEEQDEE | 211 | Q96N96 | |
| STPSEEQDEEASQSR | 216 | Q96N96 | |
| TSPAVDLEEEEEESS | 31 | O94827 | |
| PETSSEEDLRSNSER | 786 | P0C874 | |
| NEEISSDSESESLAP | 46 | O43818 | |
| DDEASVDEPRRTETS | 641 | Q8NI35 | |
| NVATEESTEPLSEDD | 1726 | Q9Y5Y9 | |
| APTLAELDSSESEEE | 456 | Q08AE8 | |
| ISSEDSEGSTDVDEP | 326 | P23497 | |
| ETTVPTDDISSSEER | 26 | Q8WXW3 | |
| RDDQTDTSSAEVPSA | 741 | Q5VUG0 | |
| PTEGESTDSEEETSA | 276 | Q5T1R4 | |
| DEEESQDELSRPSSE | 1866 | Q5T1R4 | |
| ENLNTEDVSSESDPE | 1106 | Q9UQD0 | |
| SSEATTSQDEAPREE | 816 | Q2NKQ1 | |
| SEDTDSDDSSIPRNR | 1051 | Q9BYW2 | |
| ETAEESAPDSTEFTE | 1201 | Q96JG9 | |
| RESSVDSRTISEPDE | 336 | O95049 | |
| APATEESSSSSEEEE | 916 | Q8N1G0 | |
| ASSEVSPESQEDSET | 236 | Q8TD55 | |
| SPDDSDNSVSESLDE | 46 | Q14139 | |
| TSSEEEDSRREEPSL | 491 | O43314 | |
| NSDTDEDEETEPSSS | 196 | Q86XD8 | |
| AESENEEESPRQESS | 26 | Q9UEG4 | |
| PRQEDSDSEEVSSES | 1156 | O15016 | |
| STEEDSSQDDDSEPI | 576 | Q5T4S7 | |
| TSAAEPRESESEEAE | 186 | Q8NAF0 | |
| ESVRDEPDSDSSLEV | 1411 | Q9H2Y7 | |
| EDLQSSRDRDETPSS | 411 | P51811 | |
| TLDDDVFAETEEPSS | 966 | Q7Z3T8 | |
| DPELEEALTSASDTE | 116 | Q9NYL9 | |
| SDESVPELEEQDSTQ | 31 | Q13765 | |
| SDESVPELEEQDSTQ | 31 | Q9BZK3 | |
| QLASRETSDSSEPEE | 501 | Q8NFW9 |